These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 32538493)
1. Generation of a novel CD30 Higashioka K; Kikushige Y; Ayano M; Kimoto Y; Mitoma H; Kikukawa M; Akahoshi M; Arinobu Y; Horiuchi T; Akashi K; Niiro H Clin Exp Immunol; 2020 Sep; 201(3):233-243. PubMed ID: 32538493 [TBL] [Abstract][Full Text] [Related]
2. BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance. Matsushita T; Kobayashi T; Mizumaki K; Kano M; Sawada T; Tennichi M; Okamura A; Hamaguchi Y; Iwakura Y; Hasegawa M; Fujimoto M; Takehara K Sci Adv; 2018 Jul; 4(7):eaas9944. PubMed ID: 30009261 [TBL] [Abstract][Full Text] [Related]
3. Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma. Aung WW; Wang C; Xibei J; Horii M; Mizumaki K; Kano M; Okamura A; Kobayashi T; Matsushita T J Dermatol Sci; 2021 Mar; 101(3):174-184. PubMed ID: 33451905 [TBL] [Abstract][Full Text] [Related]
4. Splenic Innate B1 B Cell Plasmablasts Produce Sustained Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-3 Cytokines during Murine Malaria Infections. Chin SS; Chorro L; Chan J; Lauvau G Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31591168 [TBL] [Abstract][Full Text] [Related]
5. A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern. Ebner S; Hofer S; Nguyen VA; Fürhapter C; Herold M; Fritsch P; Heufler C; Romani N J Immunol; 2002 Jun; 168(12):6199-207. PubMed ID: 12055233 [TBL] [Abstract][Full Text] [Related]
6. Effector and regulatory B-cell imbalance in systemic sclerosis: cooperation or competition? Liu M Clin Rheumatol; 2024 Sep; 43(9):2783-2789. PubMed ID: 39080112 [TBL] [Abstract][Full Text] [Related]
7. Tofacitinib inhibits granulocyte-macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils. Furuya MY; Asano T; Sumichika Y; Sato S; Kobayashi H; Watanabe H; Suzuki E; Kozuru H; Yatsuhashi H; Koga T; Ohira H; Sekine H; Kawakami A; Migita K Arthritis Res Ther; 2018 Aug; 20(1):196. PubMed ID: 30157949 [TBL] [Abstract][Full Text] [Related]
8. Feasibility to generate monocyte-derived dendritic cell from coculture with melanoma tumor cells in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-4. Kim YT; Hersh EM; Trevor KT Am J Reprod Immunol; 2003 Apr; 49(4):230-8. PubMed ID: 12852497 [TBL] [Abstract][Full Text] [Related]
9. Role of cysteinyl leukotrienes in human allergen-specific Th2 responses induced by granulocyte macrophage-colony stimulating factor. Faith A; Fernandez MH; Caulfield J; Loke TK; Corrigan C; O'Connor B; Lee TH; Hawrylowicz CM Allergy; 2008 Feb; 63(2):168-75. PubMed ID: 18186807 [TBL] [Abstract][Full Text] [Related]
10. Granulocyte Macrophage-Colony Stimulating Factor Produces a Splenic Subset of Monocyte-Derived Dendritic Cells That Efficiently Polarize T Helper Type 2 Cells in Response to Blood-Borne Antigen. Ryu SH; Shin HS; Eum HH; Park JS; Choi W; Na HY; In H; Kim TG; Park S; Hwang S; Sohn M; Kim ED; Seo KY; Lee HO; Lee MG; Chu MK; Park CG Front Immunol; 2021; 12():767037. PubMed ID: 35069539 [TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor drives monocytes to CD14low CD83+ DCSIGN- interleukin-10-producing myeloid cells with differential effects on T-cell subsets. Ganguly D; Paul K; Bagchi J; Rakshit S; Mandal L; Bandyopadhyay G; Bandyopadhyay S Immunology; 2007 Aug; 121(4):499-507. PubMed ID: 17433076 [TBL] [Abstract][Full Text] [Related]
12. Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli. Bechetoille N; André V; Valladeau J; Perrier E; Dezutter-Dambuyant C J Leukoc Biol; 2006 Jul; 80(1):45-58. PubMed ID: 16614258 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release. Oehler L; Foedinger M; Koeller M; Kollars M; Reiter E; Bohle B; Skoupy S; Fritsch G; Lechner K; Geissler K Blood; 1997 Feb; 89(4):1147-53. PubMed ID: 9028936 [TBL] [Abstract][Full Text] [Related]
14. IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells. Noster R; Riedel R; Mashreghi MF; Radbruch H; Harms L; Haftmann C; Chang HD; Radbruch A; Zielinski CE Sci Transl Med; 2014 Jun; 6(241):241ra80. PubMed ID: 24944195 [TBL] [Abstract][Full Text] [Related]
15. Altered B lymphocyte homeostasis and functions in systemic sclerosis. Forestier A; Guerrier T; Jouvray M; Giovannelli J; Lefèvre G; Sobanski V; Hauspie C; Hachulla E; Hatron PY; Zéphir H; Vermersch P; Labalette M; Launay D; Dubucquoi S Autoimmun Rev; 2018 Mar; 17(3):244-255. PubMed ID: 29343447 [TBL] [Abstract][Full Text] [Related]
16. JAK inhibitors impair GM-CSF-mediated signaling in innate immune cells. Fujita Y; Matsuoka N; Temmoku J; Furuya-Yashiro M; Asano T; Sato S; Matsumoto H; Watanabe H; Kozuru H; Yatsuhashi H; Kawakami A; Migita K BMC Immunol; 2020 Jun; 21(1):35. PubMed ID: 32539713 [TBL] [Abstract][Full Text] [Related]
17. Differentiation potential of CD14+ monocytes into myofibroblasts in patients with systemic sclerosis. Binai N; O'Reilly S; Griffiths B; van Laar JM; Hügle T PLoS One; 2012; 7(3):e33508. PubMed ID: 22432031 [TBL] [Abstract][Full Text] [Related]
18. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy. Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB Am J Respir Cell Mol Biol; 1995 May; 12(5):567-78. PubMed ID: 7742019 [TBL] [Abstract][Full Text] [Related]
19. Increased expression levels of FcγRIIB on naïve and double-negative memory B cells in patients with systemic sclerosis. Yagi-Numata N; Matsushita T; Takehara K; Hamaguchi Y Clin Exp Rheumatol; 2019; 37 Suppl 119(4):23-31. PubMed ID: 30719970 [TBL] [Abstract][Full Text] [Related]
20. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients. Aravena O; Ferrier A; Menon M; Mauri C; Aguillón JC; Soto L; Catalán D Arthritis Res Ther; 2017 Jan; 19(1):8. PubMed ID: 28103916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]